Fischer Pharmaceuticals launches REMIND, a PS product based on OmegaPS, an active nutrient developed by Enzymotec
Fischer Pharmaceuticals, a multi-national company specializing in and manufacturing advanced health care preparations in the fields of dermatology, ophthalmology and nutraceuticals has launched REMIND, a natural and proprietary blend of PS and DHA developed recently by Enzymotec. The company strategy is to target forty plus years old consumers who are more conscious about their brain health. REMIND will be marketed to pharmacies and drugstores in Israel.
âThe Israeli market is well educated about natural supplements solutions and therefore is ready to consume advance brain health formulas,â says Sagit Betser Enzymotec's marketing manager. âThe Israeli supplement market is fast growing and it has a 17% growth rate over the last year.â
OmegaPSâ¢ offered by Enzymotec is a natural and proprietary blend of PS and DHA contributing to brain-health. It contains 100mg of PS and 500mg of DHA in each daily serving, which provides a comprehensive defense for cognitive health.
Phosphatidylserine (PS) is a natural compound, is an essential constituent of brain membranes and an important player in brain-related biochemical pathways and cognitive-related processes. DHA has been known to be one of the prominent building-blocks of our brain cells' membrane. Growing clinical evidence supports the essential role of DHA in neuronal functions.
A recent clinical study conducted by Professor Inna Weiner of the Department of Psychology at Tel-Aviv University, supports the beneficial cognitive performance of Remind. Enzymotecâs novel OmegaPS active ingredient provides a more effective protection. Interestingly, the effect was induced while using only one third of the active ingredient concentration, compared to previous publications.
For more information, please contact:
Ms. Sagit Betser
E-mail: [email protected]